Tri-estarylla Kit
Product Images NDC 63629-2350

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tri-estarylla (NDC 63629-2350). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 2

Fig 2
This text provides information on various studies related to women's contraceptive use, including their ever use and current use. The studies include the NICHD Women's Contraceptive Study from 2002, the French E3N cohort study from 2005, the Shangal Women's Health study from 2009, The Nurses' Health Study I from 2010, and the Oxford Family Planning Association Study from 2013. It also features information on the effect estimate (OR/RR) but lacks complete information as it references specific data points that are not clear.*
FDA Label Image

Chemical Structure 1 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 02)

Chemical Structure 1 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 02)
FDA Label Image

Chemical Structure 2 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 03)

Chemical Structure 2 (B4ca5260 1e51 4bfd A22e Fd2595f1f812 03)
Ethinyl Estradiol is a synthetic estrogen commonly used in combination with a progestin as a component of hormonal contraceptives.*
FDA Label Image

Figure (B4ca5260 1e51 4bfd A22e Fd2595f1f812 04)

Figure (B4ca5260 1e51 4bfd A22e Fd2595f1f812 04)
This appears to be a chart displaying information about different birth control methods and their effectiveness in preventing pregnancy. It shows that fewer than 1 pregnancy occurs per 100 women per year for some methods, such as implants, injections, intrauterine devices, and sterilization. Other methods, such as birth control pills, skin patches, vaginal rings, condoms, and diaphragms have varying success rates in preventing pregnancy. The chart also includes suggestions for alternative methods, such as avoiding sex during the most fertile days of the monthly cycle, using spermicide, and practicing withdrawal.*
FDA Label Image

Label (Lbl636292350)

Label (Lbl636292350)
This is a medication called Norgestimate and Ethinyl Estradiol Tablets, USP containing different dosages of norgestimate and ethinyl estradiol. It comes in a package of 84 tablets with 3 sets of 28 blister cards. The white tablet contains 0.18 mg norgestimate and 0.035 mg of ethinyl estradiol while the active light blue tablet contains 0.215 mg norgestimate and 0.035 mg of ethinyl estradiol. The active blue tablet contains 0.25 mg norgestimate and 0.035 mg of ethinyl estradiol. The green tablet however does not contain active ingredients. It is important to keep the medication away from children as the package is not child resistant. The medication should also be stored at room temperature away from light.*
FDA Label Image

Tri-estar (Tri Estar)

Tri-estar (Tri Estar)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.